JP2016513692A5 - - Google Patents

Download PDF

Info

Publication number
JP2016513692A5
JP2016513692A5 JP2016502404A JP2016502404A JP2016513692A5 JP 2016513692 A5 JP2016513692 A5 JP 2016513692A5 JP 2016502404 A JP2016502404 A JP 2016502404A JP 2016502404 A JP2016502404 A JP 2016502404A JP 2016513692 A5 JP2016513692 A5 JP 2016513692A5
Authority
JP
Japan
Prior art keywords
receptor antagonist
pharmaceutical composition
cetirizine
famotidine
diarrhea
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016502404A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016513692A (ja
JP6313417B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/027323 external-priority patent/WO2014152420A2/en
Publication of JP2016513692A publication Critical patent/JP2016513692A/ja
Publication of JP2016513692A5 publication Critical patent/JP2016513692A5/ja
Application granted granted Critical
Publication of JP6313417B2 publication Critical patent/JP6313417B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016502404A 2013-03-14 2014-03-14 下痢を治療するための製品及び方法 Active JP6313417B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361782608P 2013-03-14 2013-03-14
US61/782,608 2013-03-14
PCT/US2014/027323 WO2014152420A2 (en) 2013-03-14 2014-03-14 Product and method for treating diarrhea

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018054088A Division JP6473254B2 (ja) 2013-03-14 2018-03-22 下痢を治療するための製品及び方法

Publications (3)

Publication Number Publication Date
JP2016513692A JP2016513692A (ja) 2016-05-16
JP2016513692A5 true JP2016513692A5 (https=) 2017-09-07
JP6313417B2 JP6313417B2 (ja) 2018-04-18

Family

ID=50680150

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2016502404A Active JP6313417B2 (ja) 2013-03-14 2014-03-14 下痢を治療するための製品及び方法
JP2018054088A Active JP6473254B2 (ja) 2013-03-14 2018-03-22 下痢を治療するための製品及び方法
JP2019009896A Active JP6790140B2 (ja) 2013-03-14 2019-01-24 下痢を治療するための製品及び方法
JP2020184294A Pending JP2021046400A (ja) 2013-03-14 2020-11-04 下痢を治療するための製品及び方法

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2018054088A Active JP6473254B2 (ja) 2013-03-14 2018-03-22 下痢を治療するための製品及び方法
JP2019009896A Active JP6790140B2 (ja) 2013-03-14 2019-01-24 下痢を治療するための製品及び方法
JP2020184294A Pending JP2021046400A (ja) 2013-03-14 2020-11-04 下痢を治療するための製品及び方法

Country Status (20)

Country Link
US (4) US9717726B2 (https=)
EP (3) EP3269364B1 (https=)
JP (4) JP6313417B2 (https=)
KR (4) KR20200100211A (https=)
CN (2) CN105324112B (https=)
AU (3) AU2014239878B2 (https=)
BR (2) BR112015022513A2 (https=)
CA (1) CA2906005C (https=)
DK (1) DK2968205T3 (https=)
ES (2) ES2743604T3 (https=)
HK (1) HK1247557B (https=)
HU (1) HUE035201T2 (https=)
IL (3) IL273377B2 (https=)
MX (2) MX366329B (https=)
MY (1) MY175326A (https=)
PL (1) PL2968205T3 (https=)
PT (1) PT2968205T (https=)
RU (1) RU2015143475A (https=)
WO (1) WO2014152420A2 (https=)
ZA (1) ZA201708539B (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9717726B2 (en) 2013-03-14 2017-08-01 Maregade Rx, LLC Product and method for treating diarrhea
WO2015073573A1 (en) * 2013-11-14 2015-05-21 Jacobs Michael M Compositions and methods for the prevention and treatment of alcohol-induced hangover syndrome
EP3558296B1 (en) * 2016-12-23 2023-06-28 Maregade RX, LLC Low dose product and method for treating diarrhea
IT201900012645A1 (it) * 2019-07-23 2021-01-23 Eros Zanotti Una composizione farmaceutica per l'uso nel trattamento delle chinetosi
US11424105B2 (en) * 2019-08-05 2022-08-23 Hitachi High-Tech Corporation Plasma processing apparatus
CN115515435A (zh) * 2020-02-11 2022-12-23 沃尔夫森医疗中心 有效治疗溃疡性结肠炎的方法
US12586760B2 (en) 2021-08-23 2026-03-24 Hitachi High-Tech Corporation Plasma processing apparatus and plasma processing method
US20240277700A1 (en) * 2021-09-22 2024-08-22 II Reed B. Hogan Compositions and methods for treating and preventing interstitial cystitis

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5204118A (en) 1989-11-02 1993-04-20 Mcneil-Ppc, Inc. Pharmaceutical compositions and methods for treating the symptoms of overindulgence
US5096894A (en) * 1990-04-03 1992-03-17 Bristol-Myers Squibb Company Rice dextrin oral rehydration solution
AU7255094A (en) 1993-07-06 1995-02-06 Mcneil-Ppc, Inc. H2 antagonist-antihistamine combinations
US6264984B1 (en) * 1999-12-06 2001-07-24 Bristol-Myers Squibb Company Effervescent histamine H2 antagonist composition
US6656492B2 (en) * 2000-06-30 2003-12-02 Yamanouchi Pharmaceutical Co., Ltd. Quick disintegrating tablet in buccal cavity and manufacturing method thereof
AU2100402A (en) 2000-11-30 2002-06-11 Bio Balance Corp Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications
CA2690483C (en) * 2001-11-23 2012-07-24 Janssen Pharmaceutica N.V. The use of anti-histaminics for acute reduction of elevated intracranial pressure
SE528789C2 (sv) 2004-09-10 2007-02-13 Sandvik Intellectual Property PVD-belagt skär av hårdmetall samt sätt att tillverka detta
US20070077300A1 (en) * 2005-09-30 2007-04-05 Wynn David W Oral compositions containing a salivation inducing agent
WO2007111945A2 (en) 2006-03-22 2007-10-04 Trustees Of Boston University Method for management of diarrhea
US8207188B2 (en) 2006-04-07 2012-06-26 Michalis Nicolaou Treatment of diseases modulated by a H4 receptor agonist
US20070254050A1 (en) * 2006-05-01 2007-11-01 Quart Barry D Method for treatment of diarrhea-predominant irritable bowel syndrome
US20090042972A1 (en) * 2006-05-19 2009-02-12 Somaxon Pharmaceuticals, Inc. Methods of using low-dose doxepin for the improvement of sleep
EP2526938A3 (en) 2007-02-12 2013-06-12 Mike Nicolaou Histidine decarboxylase inhibitor sole or combined with a leukotriene receptor antagonist, an anti-H1 and/or an anti-H2 to treat COPD or gastrointestinal disorders.
CA2721133C (en) * 2007-04-13 2018-11-06 Somaxon Pharmaceuticals, Inc. Low-dose doxepin formulations and methods of making and using the same
US8263581B2 (en) 2009-07-03 2012-09-11 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
CN105051192B (zh) 2012-11-13 2020-04-17 科迪艾克生物科学公司 治疗剂的递送
US9717726B2 (en) 2013-03-14 2017-08-01 Maregade Rx, LLC Product and method for treating diarrhea
EP3558296B1 (en) 2016-12-23 2023-06-28 Maregade RX, LLC Low dose product and method for treating diarrhea

Similar Documents

Publication Publication Date Title
JP2016513692A5 (https=)
JP6790140B2 (ja) 下痢を治療するための製品及び方法
HK1247557A1 (en) Product and method for treating diarrhea
US20250325540A1 (en) Low dose product and method for treating diarrhea
HK1213205B (en) Product and method for treating diarrhea